selected publications
-
academic article
-
ABCA7 and risk of dementia and vascular disease in the Danish population.
Annals of Clinical and Translational Neurology.
5.
2018
Absolute 10-year risk of dementia by age, sex and APOE genotype: a population-based cohort study.
Canadian Medical Association Journal.
190.
2018
An updated Alzheimer hypothesis: Complement C3 and risk of Alzheimer's disease—A cohort study of 95,442 individuals.
Alzheimer's & Dementia.
14.
2018
Effects of menopause and high-intensity training on insulin sensitivity and muscle metabolism.
Menopause The Journal of The North American Menopause Society.
25.
2018
Genetic variants in CYP7A1 and risk of myocardial infarction and symptomatic gallstone disease..
European Heart Journal.
39.
2018
Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals.
BMC Medicine.
16.
2018
Naturally Occurring Variants in LRP1 (Low-Density Lipoprotein Receptor–Related Protein 1) Affect HDL (High-Density Lipoprotein) Metabolism Through ABCA1 (ATP-Binding Cassette A1) and SR-B1 (Scavenger Receptor Class B Type 1) in Humans.
Arteriosclerosis Thrombosis and Vascular Biology.
38.
2018
Osteoporosis Is Associated with Deteriorating Clinical Status in Adults with Cystic Fibrosis.
International Journal of Endocrinology.
2018.
2018
Plasma apolipoprotein E levels and risk of dementia: A Mendelian randomization study of 106,562 individuals.
Alzheimer's & Dementia.
14.
2018
Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.
Nature Genetics.
50.
2018
Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.
Nature Genetics.
50.
2018
Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.
Nature Genetics.
50.
2018
The extent of B‐cell activation and dysfunction preceding lymphoma development in HIV‐positive people.
HIV Medicine.
19.
2018
U-shaped relationship of HDL and risk of infectious disease: two prospective population-based cohort studies.
European Heart Journal.
39.
2018
Adiposity, Dysmetabolic Traits and Earlier Onset of Female Puberty in Adolescent Offspring of Women With Gestational Diabetes Mellitus: A Clinical Study Within the Danish National Birth Cohort.
Diabetes Care.
40.
2017
Aerobic exercise training lowers platelet reactivity and improves platelet sensitivity to prostacyclin in pre‐ and postmenopausal women.
Journal of Thrombosis and Haemostasis.
15.
2017
Body Mass Index and Risk of Alzheimer’s Disease: A Mendelian Randomization Study of 399,536 Individuals.
The Journal of Clinical Endocrinology & Metabolism.
102.
2017
Exome-wide association study of plasma lipids in >300,000 individuals.
Nature Genetics.
49.
2017
Genetic variants in CYP7A1 and risk of myocardial infarction and symptomatic gallstone disease.
Atherosclerosis.
263.
2017
Genetic variation in WRN and ischemic stroke: General population studies and meta-analyses.
Experimental Gerontology.
89.
2017
Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease.
Nature Genetics.
49.
2017
Leg vascular and skeletal muscle mitochondrial adaptations to aerobic high‐intensity exercise training are enhanced in the early postmenopausal phase.
The Journal of Physiology.
595.
2017
Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer’s disease and Parkinson’s disease: Mendelian randomisation study.
The BMJ.
357.
2017
Rare and low-frequency coding variants alter human adult height.
Nature.
542.
2017
The Bipolar Illness Onset study: research protocol for the BIO cohort study.
BMJ Open.
7.
2017
Using genetics to explore whether the cholesterol-lowering drug ezetimibe may cause an increased risk of cancer..
International Journal of Epidemiology.
46.
2017
Data on plasma levels of apolipoprotein E, correlations with lipids and lipoproteins stratified by APOE genotype, and risk of ischemic heart disease.
Data in Brief.
6.
2016
Loss-of-function mutations in APOC3, remnant cholesterol, LDL cholesterol, and risk of ischemic vascular disease.
Atherosclerosis.
252.
2016
Low LDL-cholesterol, PCSK9 and HMGCR genetic variation, and risk of neurodegenerative disease: A mendelian randomization study.
Atherosclerosis.
252.
2016
Plasma levels of apolipoprotein E and risk of ischemic heart disease in the general population.
Atherosclerosis.
246.
2016
Relation between plasma and brain lipids.
Current Opinion in Lipidology.
27.
2016
Functional mutation in ABCA1, plasma levels of apolipoprotein E and risk of alzheimer disease and cerebrovascular disease.
Atherosclerosis.
241.
2015
Genetic and environmental determinants of 25-hydroxyvitamin D levels in multiple sclerosis.
Multiple Sclerosis Journal.
21.
2015
Genetic variation in the cholesterol transporter NPC1L1, ischaemic vascular disease, and gallstone disease.
European Heart Journal.
36.
2015
HDL Cholesterol and Risk of Type 2 Diabetes: A Mendelian Randomization Study.
Diabetes.
64.
2015
Loss‐of‐function mutation in ABCA1 and risk of Alzheimer's disease and cerebrovascular disease.
Alzheimer's & Dementia.
11.
2015
Plasma levels of apolipoprotein E and risk of dementia in the general population.
Annals of Neurology.
77.
2015
Subgroups at high risk for ischaemic heart disease:identification and validation in 67 000 individuals from the general population.
International Journal of Epidemiology.
44.
2015
A systematic review and meta-analysis of 130,000 individuals shows smoking does not modify the association of APOE genotype on risk of coronary heart disease.
Atherosclerosis.
237.
2014
Genetically reduced high-density lipoprotein cholesterol and risk of type 2 diabetes: A mendelian randomization study.
Atherosclerosis.
235.
2014
Importance of non-synonymous genetic variation in wrn on risk of ischemic vascular disease and mortality in the general population.
Atherosclerosis.
235.
2014
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease.
New England Journal of Medicine.
371.
2014
Loss-of-function mutations in APOC3 and reduced risk of ischemic vascular disease.
Atherosclerosis.
235.
2014
Mutations in Danish patients with long QT syndrome and the identification of a large founder family with p.F29L in KCNH2.
BMC Medical Genetics.
15.
2014
Response to Letter Regarding Article, “Visible Age-Related Signs and Risk of Ischemic Heart Disease in the General Population.
Circulation.
130.
2014
The ABCG5/8 Cholesterol Transporter and Myocardial Infarction Versus Gallstone Disease.
Journal of the American College of Cardiology.
63.
2014
Validated context-dependent associations of coronary heart disease risk with genotype variation in the chromosome 9p21 region: the Atherosclerosis Risk in Communities study.
Human Genetics.
133.
2014
Visible Age-Related Signs and Risk of Ischemic Heart Disease in the General Population.
Circulation.
129.
2014
-
hide from search
-
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.
Human Molecular Genetics.
2013
Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: Systematic review and meta-analysis of 14 015 stroke cases and pooled analysis of primary biomarker data from up to 60 883 individuals.
International Journal of Epidemiology.
2013
Extreme Bilirubin Levels as a Causal Risk Factor for Symptomatic Gallstone Disease.
JAMA Internal Medicine.
2013
Characteristics of APOA1 S36A, F71Y, K107del, and L144R heterozygotes and noncarriers in the Copenhagen City Heart Study (n = 10,330) and the Copenhagen General Population study (n = 45,239)..
public-library-of-science.
2012
Number of nonsynonymous and synonymous variants identified in APOA1 by apoA-I percentiles..
public-library-of-science.
2012
Population-Based Resequencing of APOA1 in 10,330 Individuals: Spectrum of Genetic Variation, Phenotype, and Comparison with Extreme Phenotype Approach.
public-library-of-science.
2012
-
patent
-
METHOD OF PROGNOSIS
2015